Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare giant — denies it is “pushing ...

Glenview to meet top CVS execs, propose operational improvements, WSJ reports. By Reuters. September 30, 2024 12:25 AM UTC Updated September 30, 2024 A general view shows a sign of ...

This meeting comes as Glenview, led by founder Larry Robbins, has invested ~$700M in CVS (NYSE:CVS), which constitutes a significant portion of his $2.5B hedge fund.Glenview currently owns about 1 ...

CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround efforts.

Glenview said its shares in CVS had generated a 25% return since it made purchases in May 2024. Its role as a major investor gave it the scale needed to have key conversations with leaders and ...

Glenview released the following statement following reports that it is pushing for a break-up of CVS Health. "We appreciate the skill and dedication of everyone at CVS Health and their daily ...

Otherwise, Glenview would ask for cost-cutting measures, but CVS announced job losses today - 2.9k in total, which is about 1% of all staff - and has pledged to save $2bn in costs via the use of ...

Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. — about a third of its stake — and said it was pleased with recent changes at the health care ...

CVS also will lay off less than 1% of its workforce; its shares have fallen 24% this year. ... The slated meeting, between CVS and hedge fund Glenview Capital Management, ...

CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that’s been pressuring the company for change.

Glenview Capital Management will reportedly meet top executives at CVS Health to suggest ways it can improve operations, per a Reuters report, which cited a Wall Street Journal report on Sunday.

CVS market cap at $77.2B. Glenview’s position is a sign of Robbins’s belief in the company’s potential and his confidence that he can get executives to pursue a new path, ...